BioMedica2021年书

 

BioMedica2021年书

关于“正牌代理商”栏目的声明

“正牌代理商”栏目设立的初衷是为了让读者在购买产品时能更快找到厂家的代理商,不用一张一张地翻名片,也不用担心买到水货和假货。基于这个初衷,我们收录了多个品牌的代理商,并在签订合同时进行了严格的审核。各厂家或代理商以合同的形式对其代理信息的真实性和准确性进行了保证。       然而,由于生物产品市场的复杂性,尽管我们进行了严格的审核,也不能保证信息的*准确和实时更新。基于此,今后我们会尽我们最大的努力去进行更严格的审核,也希望各厂家和代理商配合和谅解。

BioMedica中国代理,BioMedica上海代理,BioMedica北京代理,BioMedica广东代理,BioMedica江苏代理BioMedica湖北代理,BioMedica天津代理,BioMedica黑龙江代理,BioMedica湖南代理BioMedica内蒙古代理,BioMedica吉林代理,BioMedica福建代理,BioMedica江苏代理,BioMedica浙江代理,BioMedica四川代理,BioMedica代理

 

BioMedica Diagnostics 238L COA


BioMedica Diagnostics是一家自豪的加拿大公司,专注于为人类和动物健康领域提供定制的经济实惠的诊断解决方案。

BioMedica Diagnostics 238L 说明书

SAFETY DATA SHEET

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1. Product identifier

 

Trade name or designation of the mixture

Registration number Synonyms

Product code Issue date Version number

SPECTROZYME® TH 50 umole

 

None.     

238L

01-December-2017

02

 

Revision date 11-July-2017

Supersedes date 14-July-2015

1.2. Relevant identified uses of the substance or mixture and uses advised against

 

Identified uses

Uses advised against

Research use only.

Use in accordance with supplier's recommendations.

SECTION 2: Hazards identification

2.1. Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

Classification according to Regulation (EC) 272/2008 as amended

Health hazards

 

Skin corrosion/irritation

Serious eye damage/eye irritation

 

Specific target organ toxicity – single exposure

Category 2

Category 2

 

Category 3 respiratory tract irritation

H315 – Causes skin irritation.

H319 – Causes serious eye irritation.

H335 – May cause respiratory irritation.

 

Hazard summary Irritating to eyes, respiratory system and skin.

2.2. Label elements

Label according to Regulation (EC) 272/2008 as amended

Contains: H-D-cyclohexylalanyl-alanyl-arginine-para-nitroanilide diacetate saltt

Hazard pictograms

 

 

 

Signal word Warning

 

Hazard statements

H315 Causes skin irritation.

H319 Causes serious eye irritation.

H335 May cause respiratory irritation.

 

P261 Avoid breathing dust.

P264 Wash thoroughly after handling.

P271 Use only outdoors or in a well-ventilated area.

P280 Wear protective gloves.

P280 Wear eye/face protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of water.

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

P312 Call a POISON CENTER/doctor if you feel unwell. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.

P362 + P364 Take off contaminated clothing and wash it before reuse.

Storage

P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label information None.

2.3. Other hazards Not a PBT or vPvB substance or mixture.

SECTION 3: Composition/information on ingredients

 

Chemical name

% CAS-No / EC

No

REACH Registration No

INDEX No

Notes

 

 

 

H-D-cyclohexylalanyl-alanyl-arginine- para-nitroanilide diacetate saltt

45 – 65

None  

 

Classification: Skin Irrit. 2;H315, Eye Irrit. 2;H319, STOT SE 3;H335

 

 

Glycine

 

Classification: 

20 – 40

56-40-6  

200-272-2

 

Composition comments

All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.

 

SECTION 4: First aid measures

 

General information

Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves. If you feel unwell, seek medical advice (show the label where possible).

 

4.1. Description of first aid measures

 

Inhalation Skin contact Eye contact

 

Ingestion

4.2. Most important symptoms and effects, both acute and delayed

4.3. Indication of any immediate medical attention and special treatment needed

Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or doctor/physician if you feel unwell.

Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Wash contaminated clothing before reuse.

Do not rub eyes. Immediay flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists.

Rinse mouth. Get medical attention if symptoms occur.

May cause redness and pain. Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting.

 

Provide general supportive measures and treat symptomatically.

 

SECTION 5: Firefighting measures

 

General fire hazards

5.1. Extinguishing media Suitable extinguishing media

Unsuitable extinguishing media

5.2. Special hazards arising from the substance or mixture

5.3. Advice for firefighters Special protective equipment for firefighters

Special fire fighting procedures

No unusual fire or explosion hazards noted. Will burn if involved in a fire.

 

Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2). Do not use water jet as an extinguisher, as this will spread the fire. During fire, gases hazardous to health may be formed.

 

Self-contained breathing apparatus and full protective clothing must be worn in case of fire. Use standard firefighting procedures and consider the hazards of other involved materials.

 

SECTION 6: Accidental release measures

6.1. Personal precautions, protective equipment and emergency procedures

 

For non-emergency personnel

 

 

For emergency responders

 

6.2. Environmental precautions

6.3. Methods and material for containment and cleaning up

 

 

 

 

 

6.4. Reference to other sections

Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of dust. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained.

Keep unnecessary personnel away. Use personal protection recommended in section 8 of the SDS.

Avoid discharge into drains, water courses or onto the ground.

Avoid dispersal of dust in the air (i.e., clearing dust surfaces with compressed air). Collect dust using a vacuum cleaner equipped with HEPA filter. Stop the flow of material, if this is without risk.

 

Large Spills: Wet down with water and dike for later disposal. Shovel the material into waste container. Following product recovery, flush area with water.

 

Small Spills: Sweep up or vacuum up spillage and collect in suitable container for disposal. Clean surface thoroughly to remove residual contamination.

For personal protection, see section 8. For waste disposal, see section 13 of the SDS.

 

SECTION 7: Handling and storage

 

7.1. Precautions for safe handling

 

 

7.2. Conditions for safe storage, including any incompatibilities

7.3. Specific end use(s)

Minimise dust generation and accumulation. Provide appropriate exhaust ventilation at places where dust is formed. Avoid breathing dust. Avoid contact with eyes, skin, and clothing. Avoid prolonged exposure. Wear appropriate personal protective equipment. Observe good industrial hygiene practices.

Store locked up. Store in original tightly closed container. Store in a well-ventilated place. Store away from incompatible materials (see section 10 of the SDS).

 

Research use only.

 

SECTION 8: Exposure controls/personal protection

8.1. Control parameters

 

Occupational exposure limits Biological limit values

Recommended monitoring procedures

No exposure limits noted for ingredient(s).

No biological exposure limits noted for the ingredient(s). Follow standard monitoring procedures.

 

Derived no-effect level (DNEL) Not available.

 

Predicted no effect concentrations (PNECs)

8.2. Exposure controls

Not available.

 

Appropriate engineering controls

Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. If engineering measures are not sufficient to maintain concentrations of dust particulates below the OEL (occupational exposure limit), suitable respiratory protection must be worn. If material is ground, cut, or used in any operation which may generate dusts, use appropriate local exhaust ventilation to keep exposures below the recommended exposure limits. Eye wash facilities and emergency shower must be available when handling this product.

 

Individual protection measures, such as personal protective equipment

 

General information

 

 

Eye/face protection Skin protection

– Hand protection

 

– Other

Respiratory protection

 

Thermal hazards Hygiene measures

 

Environmental exposure controls

Use personal protective equipment as required. Personal protection equipment should be chosen according to the CEN standards and in discussion with the supplier of the personal protective equipment.

Wear safety goggles and a face shield.

 

Wear appropriate chemical resistant gloves. Suitable gloves can be recommended by the glove supplier.

Wear appropriate chemical resistant clothing.

In case of inadequate ventilation or risk of inhalation of dust or fumes, use suitable respiratory equipment.

Wear appropriate thermal protective clothing, when necessary.

Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.

Environmental manager must be informed of all major releases.

 

SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties Appearance

 

Physical state Form

Colour Odour

Solid.

White powder.

White.

Not available.

 

Odour threshold Not available.

pH Not available.

Melting point/freezing point Not available.

 

Initial boiling point and boiling range

Not available.

 

Flash point Not available.

Evaporation rate Not available.

Flammability (solid, gas) Not available.

Upper/lower flammability or explosive limits

 

Flammability limit – lower (%)

Flammability limit – upper (%)

Not available.

 

Not available.

 

Vapour pressure Not available.

Vapour density Not available.

Relative density Not available.

Solubility(ies) Soluble in water.

 

Partition coefficient (n-octanol/water)

Not available.

 

Auto-ignition temperature Not available. Decomposition temperature Not available. Viscosity Not available.

 

Explosive properties Oxidizing properties

9.2. Other information

Not available.

Not available.

No relevant additional information available.

 

SECTION 10: Stability and reactivity

 

10.1. Reactivity

10.2. Chemical stability

10.3. Possibility of hazardous reactions

10.4. Conditions to avoid

10.5. Incompatible materials

10.6. Hazardous decomposition products

The product is stable and non-reactive under normal conditions of use, storage and transport. Material is stable under normal conditions.

Hazardous polymerisation does not occur.

 

Contact with incompatible materials. Strong oxidising agents. Strong acids. Carbon monoxide. Carbon dioxide.

 

SECTION 11: Toxicological information

General information Occupational exposure to the substance or mixture may cause adverse effects.

Information on likely routes of exposure

Inhalation Dust may irritate respiratory system. Prolonged inhalation may be harmful.

Skin contact Causes skin irritation.

Eye contact Causes serious eye irritation.

Ingestion May cause discomfort if swallowed.

Symptoms Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting. May cause redness and pain.

11.1. Information on toxicological effects

Acute toxicity May cause discomfort if swallowed.

 

Skin corrosion/irritation

Serious eye damage/eye irritation

Causes skin irritation. Causes serious eye irritation.

 

Respiratory sensitisation Not a respiratory sensitiser.

 

Skin sensitisation Germ cell mutagenicity

Not a skin sensitiser.

No data available to indicate product or any components present at greater than 0.1% are mutagenic or genotoxic.

 

Carcinogenicity Not classifiable as to carcinogenicity to humans.

 

Reproductive toxicity

Specific target organ toxicity – single exposure

Specific target organ toxicity – repeated exposure

This product is not expected to cause reproductive or developmental effects. May cause respiratory irritation.

 

Not classified.

 

Aspiration hazard Not classified.

 

Mixture versus substance information

Not available.

 

Other information No other specific acute or chronic health impact noted.

 

SECTION 12: Ecological information

12.1. Toxicity The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.

 

12.2. Persistence and degradability

12.3. Bioaccumulative potential

Partition coefficient

n-octanol/water (log Kow)

No data is available on the degradability of this product.

 

 

Not available.

 

Bioconcentration factor (BCF) Not available.

 

12.4. Mobility in soil

12.5. Results of PBT and vPvB assessment

No data available.

Not a PBT or vPvB substance or mixture.

 

12.6. Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation potential, endocrine disruption, global warming potential) are expected from this component.

 

SECTION 13: Disposal considerations

13.1. Waste treatment methods

 

Residual waste

 

 

Contaminated packaging

 

 

EU waste code

 

Disposal methods/information

Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).

Empty containers should be taken to an approved waste handling site for recycling or disposal. Since emptied containers may retain product residue, follow label warnings even after container is emptied.

The Waste code should be assigned in discussion between the user, the producer and the waste disposal company.

Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose of contents/container in accordance with local/regional/national/international regulations.

 

SECTION 14: Transport information

ADR

Not regulated as dangerous goods.

RID

Not regulated as dangerous goods.

ADN

Not regulated as dangerous goods.

IATA

Not regulated as dangerous goods.

IMDG

Not regulated as dangerous goods.

 

14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

Not applicable.

 

SECTION 15: Regulatory information

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture EU regulations

Regulation (EC) 005/2009 on substances that deplete the ozone layer, Annex I and II, as amended

Not listed.

Regulation (EC) No 850/2004 On persistent organic pollutants, Annex I as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 1 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 2 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 3 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex V as amended

Not listed.

Regulation (EC) No 166/2006 Annex II Pollutant Release and Transfer Registry, as amended

Not listed.

Regulation (EC) 907/2006, REACH Article 59(10) Candidate List as currently published by ECHA

Not listed.

Authorisations

Regulation (EC) 907/2006, REACH Annex XIV Substances subject to authorization, as amended

Not listed.

Restrictions on use

Regulation (EC) No1907/2006, REACH Annex XVII Substances subject to restriction on marketing and use as amended

Not listed.

Directive 2004/37/EC: on the protection of workers from the risks related to exposure to carcinogens and mutagens at work, as amended

Not listed.

Directive 92/85/EEC: on the safety and health of pregnant workers and workers who have recently given birth or are breastfeeding, as amended

Not listed.

Other EU regulations

Directive 2012/18/EU on major accident hazards involving dangerous substances

Not listed.

 

Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

Not listed.

Directive 94/33/EC on the protection of young people at work

Not listed.

 

Other regulations

 

 

 

 

National regulations

15.2. Chemical safety assessment

The product is classified and labelled in accordance with Regulation (EC) 1272/2008 (CLP Regulation) as amended and respective national laws implementing EC directives. This Safety Data Sheet complies with the requirements of Regulation (EC) 907/2006.

In the European Union this product is regulated under the In Vitro Diagnostic Medical Devices Directive (98/79/EC).

Follow national regulation for work with chemical agents. No Chemical Safety Assessment has been carried out.

 

SECTION 16: Other information

List of abbreviations

 

 

 

References

Information on evaluation method leading to the classification of mixture

Full text of any H-statements not written out in full under Sections 2 to 15

 

 

Training information Disclaimer

DNEL: Derived No-Effect Level.

PNEC: Predicted No-Effect Concentration.

IARC Monographs. Overall Evaluation of Carcinogenicity

The classification for health and environmental hazards is derived by a combination of calculation methods and test data, if available.

 

 

 

H315 Causes skin irritation.

H319 Causes serious eye irritation. H335 May cause respiratory irritation.

Follow training instructions when handling this material.

The information above is provided in good faith. It is believed to be accurate and represents the best information currently available to us. HOWEVER, WE MAKE NO WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER TYPE, EXPRESSED OR IMPLIED, WITH RESPECT TO PRODUCTS DESCRIBED OR DATA OR INFORMATION PROVIDED, AND WE ASSUME NO LIABILITY RESULTING FROM THE USE OF

SUCH PRODUCTS, DATA OR INFORMATION. Users should make their own investigations to determine the suitability of the information for their particular purposes, and the user assumes all risk arising from their use of the material. The user is required to comply with all laws and regulations relating to the purchase, use, storage and disposal of the material, and must be familiar with and follow generally accepted safe handling procedures. In no event shall BioMedica Diagnostics be liable for any claims, losses, or damages of any individual or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if BioMedica Diagnostics has been advised of the possibility of such damages.

 

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

BioMedica Diagnostics 中国代理

世界*实验材料供应商 BioMedica Diagnostics正式上海金畔为其中国代理, BioMedica Diagnostics在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔一直秉承为中国科研客户带来的产品,的服务, BioMedica Diagnostics就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

BioMedica Diagnostics中国代理, BioMedica Diagnostics上海代理, BioMedica Diagnostics北京代理,BioMedica Diagnostics广东代理, BioMedica Diagnostics江苏代理BioMedica Diagnostics湖北代理,BioMedica Diagnostics天津,BioMedica Diagnostics黑龙江代理,BioMedica Diagnostics内蒙古代理,BioMedica Diagnostics吉林代理,BioMedica Diagnostics福建代理, BioMedica Diagnostics江苏代理, BioMedica Diagnostics浙江代理, BioMedica Diagnostics四川代理,

 

BioMedica Diagnostics是一家骄傲的加拿大公司,专注于在人类和动物健康领域提供定制的负担得起的诊断解决方案。

利用我们在血栓形成和止血领域的创新技术和核心竞争力,我们与上与技术开发公司和医疗保健利益相关者合作开发和制造定制的试剂和诊断解决方案,以满足新的和特定的,确定的需求。

 

凝血制品如下:

  QUIKCOAG PRODUCTS

  • QuikCoag APTT-EA

  • QuikCoag APTT-S

  • QuikCoag Calcium Chloride 0.020M

  • QuikCoag Control

  • QuikCoag Fibrinogen

  • QuikCoag Fibrinogen Kit

  • QuikCoag Imidazole Buffer

  • QuikCoag Multi Parameter Controls

  • QuikCoag PT-HS

 

Biomedica产品介绍


Biomedica产品介绍

简要描述:Biomedica总部位于奥地利的维也纳,是一家关注心脏病学,心脏外科,肾脏科,骨科,等相关领域用于人和动物的诊断试剂和生命科学产品等领域的专业的经销商。

详细介绍

产品咨询

Biomedica总部位于奥地利的维也纳,是一家关注心脏病学,心脏外科,肾脏科,骨科,等相关领域用于人和动物的诊断试剂和生命科学产品等领域的专业的经销商。

Biomedica Gruppe is a privay owned group of companies in Central Europe with its headquarters in Vienna, Austria. Founded in 1978 as a local distribution company, Biomedica has gradually established subsidiaries in neighbouring countries, Poland and on the Balkans.

Our core activities are the distribution of advanced and specialised medical devices in the fields of cardiology, cardiac surgery, nephrology, orthopaedics, intensive care, laboratory diagnostics for human and veterinary applications, and Life Sciences. Based on our IP portfolio and in cooperation with other companies and research institutions, the Austrian IVD research team is developing immunoassays for special applications that are manufactured in a dedicated production unit based in Bratislava.

Through our local offices we have a strong local sales presence with dedicated technical services, all fully ISO 9001 certified and supported by central marketing and product management. An integrated ERP, central management and controlling combine the efficiency of a multinational organisation with regional presence and customer contact in the local language.

Biomedica Gruppe is organised in several divisions in order to meet the special requirements of our different customer groups. Through our main office in Austria, we offer suppliers the unique possibility to access 12 different countries, each with their own particular requirements.

公司:www.biomedica.co.at

BioMedica Diagnostics 238L

 

BioMedica Diagnostics是一家自豪的加拿大公司,专注于为人类和动物健康领域提供定制的经济实惠的诊断解决方案。

BioMedica Diagnostics 238L 说明书

SAFETY DATA SHEET

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1. Product identifier

 

Trade name or designation of the mixture

Registration number Synonyms

Product code Issue date Version number

SPECTROZYME® TH 50 umole

 

None.     

238L

01-December-2017

02

 

Revision date 11-July-2017

Supersedes date 14-July-2015

1.2. Relevant identified uses of the substance or mixture and uses advised against

 

Identified uses

Uses advised against

Research use only.

Use in accordance with supplier's recommendations.

SECTION 2: Hazards identification

2.1. Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

Classification according to Regulation (EC) 272/2008 as amended

Health hazards

 

Skin corrosion/irritation

Serious eye damage/eye irritation

 

Specific target organ toxicity – single exposure

Category 2

Category 2

 

Category 3 respiratory tract irritation

H315 – Causes skin irritation.

H319 – Causes serious eye irritation.

H335 – May cause respiratory irritation.

 

Hazard summary Irritating to eyes, respiratory system and skin.

2.2. Label elements

Label according to Regulation (EC) 272/2008 as amended

Contains: H-D-cyclohexylalanyl-alanyl-arginine-para-nitroanilide diacetate saltt

Hazard pictograms

 

 

 

Signal word Warning

 

Hazard statements

H315 Causes skin irritation.

H319 Causes serious eye irritation.

H335 May cause respiratory irritation.

 

P261 Avoid breathing dust.

P264 Wash thoroughly after handling.

P271 Use only outdoors or in a well-ventilated area.

P280 Wear protective gloves.

P280 Wear eye/face protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of water.

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

P312 Call a POISON CENTER/doctor if you feel unwell. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.

P362 + P364 Take off contaminated clothing and wash it before reuse.

Storage

P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label information None.

2.3. Other hazards Not a PBT or vPvB substance or mixture.

SECTION 3: Composition/information on ingredients

 

Chemical name

% CAS-No / EC

No

REACH Registration No

INDEX No

Notes

 

 

 

H-D-cyclohexylalanyl-alanyl-arginine- para-nitroanilide diacetate saltt

45 – 65

None

 

Classification: Skin Irrit. 2;H315, Eye Irrit. 2;H319, STOT SE 3;H335

 

 

Glycine

 

Classification:

20 – 40

56-40-6

200-272-2

 

Composition comments

All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.

 

SECTION 4: First aid measures

 

General information

Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves. If you feel unwell, seek medical advice (show the label where possible).

 

4.1. Description of first aid measures

 

Inhalation Skin contact Eye contact

 

Ingestion

4.2. Most important symptoms and effects, both acute and delayed

4.3. Indication of any immediate medical attention and special treatment needed

Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or doctor/physician if you feel unwell.

Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Wash contaminated clothing before reuse.

Do not rub eyes. Immediay flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists.

Rinse mouth. Get medical attention if symptoms occur.

May cause redness and pain. Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting.

 

Provide general supportive measures and treat symptomatically.

 

SECTION 5: Firefighting measures

 

General fire hazards

5.1. Extinguishing media Suitable extinguishing media

Unsuitable extinguishing media

5.2. Special hazards arising from the substance or mixture

5.3. Advice for firefighters Special protective equipment for firefighters

Special fire fighting procedures

No unusual fire or explosion hazards noted. Will burn if involved in a fire.

 

Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2). Do not use water jet as an extinguisher, as this will spread the fire. During fire, gases hazardous to health may be formed.

 

Self-contained breathing apparatus and full protective clothing must be worn in case of fire. Use standard firefighting procedures and consider the hazards of other involved materials.

 

SECTION 6: Accidental release measures

6.1. Personal precautions, protective equipment and emergency procedures

 

For non-emergency personnel

 

 

For emergency responders

 

6.2. Environmental precautions

6.3. Methods and material for containment and cleaning up

 

 

 

 

 

6.4. Reference to other sections

Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of dust. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained.

Keep unnecessary personnel away. Use personal protection recommended in section 8 of the SDS.

Avoid discharge into drains, water courses or onto the ground.

Avoid dispersal of dust in the air (i.e., clearing dust surfaces with compressed air). Collect dust using a vacuum cleaner equipped with HEPA filter. Stop the flow of material, if this is without risk.

 

Large Spills: Wet down with water and dike for later disposal. Shovel the material into waste container. Following product recovery, flush area with water.

 

Small Spills: Sweep up or vacuum up spillage and collect in suitable container for disposal. Clean surface thoroughly to remove residual contamination.

For personal protection, see section 8. For waste disposal, see section 13 of the SDS.

 

SECTION 7: Handling and storage

 

7.1. Precautions for safe handling

 

 

7.2. Conditions for safe storage, including any incompatibilities

7.3. Specific end use(s)

Minimise dust generation and accumulation. Provide appropriate exhaust ventilation at places where dust is formed. Avoid breathing dust. Avoid contact with eyes, skin, and clothing. Avoid prolonged exposure. Wear appropriate personal protective equipment. Observe good industrial hygiene practices.

Store locked up. Store in original tightly closed container. Store in a well-ventilated place. Store away from incompatible materials (see section 10 of the SDS).

 

Research use only.

 

SECTION 8: Exposure controls/personal protection

8.1. Control parameters

 

Occupational exposure limits Biological limit values

Recommended monitoring procedures

No exposure limits noted for ingredient(s).

No biological exposure limits noted for the ingredient(s). Follow standard monitoring procedures.

 

Derived no-effect level (DNEL) Not available.

 

Predicted no effect concentrations (PNECs)

8.2. Exposure controls

Not available.

 

Appropriate engineering controls

Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. If engineering measures are not sufficient to maintain concentrations of dust particulates below the OEL (occupational exposure limit), suitable respiratory protection must be worn. If material is ground, cut, or used in any operation which may generate dusts, use appropriate local exhaust ventilation to keep exposures below the recommended exposure limits. Eye wash facilities and emergency shower must be available when handling this product.

 

Individual protection measures, such as personal protective equipment

 

General information

 

 

Eye/face protection Skin protection

– Hand protection

 

– Other

Respiratory protection

 

Thermal hazards Hygiene measures

 

Environmental exposure controls

Use personal protective equipment as required. Personal protection equipment should be chosen according to the CEN standards and in discussion with the supplier of the personal protective equipment.

Wear safety goggles and a face shield.

 

Wear appropriate chemical resistant gloves. Suitable gloves can be recommended by the glove supplier.

Wear appropriate chemical resistant clothing.

In case of inadequate ventilation or risk of inhalation of dust or fumes, use suitable respiratory equipment.

Wear appropriate thermal protective clothing, when necessary.

Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.

Environmental manager must be informed of all major releases.

 

SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties Appearance

 

Physical state Form

Colour Odour

Solid.

White powder.

White.

Not available.

 

Odour threshold Not available.

pH Not available.

Melting point/freezing point Not available.

 

Initial boiling point and boiling range

Not available.

 

Flash point Not available.

Evaporation rate Not available.

Flammability (solid, gas) Not available.

Upper/lower flammability or explosive limits

 

Flammability limit – lower (%)

Flammability limit – upper (%)

Not available.

 

Not available.

 

Vapour pressure Not available.

Vapour density Not available.

Relative density Not available.

Solubility(ies) Soluble in water.

 

Partition coefficient (n-octanol/water)

Not available.

 

Auto-ignition temperature Not available. Decomposition temperature Not available. Viscosity Not available.

 

Explosive properties Oxidizing properties

9.2. Other information

Not available.

Not available.

No relevant additional information available.

 

SECTION 10: Stability and reactivity

 

10.1. Reactivity

10.2. Chemical stability

10.3. Possibility of hazardous reactions

10.4. Conditions to avoid

10.5. Incompatible materials

10.6. Hazardous decomposition products

The product is stable and non-reactive under normal conditions of use, storage and transport. Material is stable under normal conditions.

Hazardous polymerisation does not occur.

 

Contact with incompatible materials. Strong oxidising agents. Strong acids. Carbon monoxide. Carbon dioxide.

 

SECTION 11: Toxicological information

General information Occupational exposure to the substance or mixture may cause adverse effects.

Information on likely routes of exposure

Inhalation Dust may irritate respiratory system. Prolonged inhalation may be harmful.

Skin contact Causes skin irritation.

Eye contact Causes serious eye irritation.

Ingestion May cause discomfort if swallowed.

Symptoms Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting. May cause redness and pain.

11.1. Information on toxicological effects

Acute toxicity May cause discomfort if swallowed.

 

Skin corrosion/irritation

Serious eye damage/eye irritation

Causes skin irritation. Causes serious eye irritation.

 

Respiratory sensitisation Not a respiratory sensitiser.

 

Skin sensitisation Germ cell mutagenicity

Not a skin sensitiser.

No data available to indicate product or any components present at greater than 0.1% are mutagenic or genotoxic.

 

Carcinogenicity Not classifiable as to carcinogenicity to humans.

 

Reproductive toxicity

Specific target organ toxicity – single exposure

Specific target organ toxicity – repeated exposure

This product is not expected to cause reproductive or developmental effects. May cause respiratory irritation.

 

Not classified.

 

Aspiration hazard Not classified.

 

Mixture versus substance information

Not available.

 

Other information No other specific acute or chronic health impact noted.

 

SECTION 12: Ecological information

12.1. Toxicity The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.

 

12.2. Persistence and degradability

12.3. Bioaccumulative potential

Partition coefficient

n-octanol/water (log Kow)

No data is available on the degradability of this product.

 

 

Not available.

 

Bioconcentration factor (BCF) Not available.

 

12.4. Mobility in soil

12.5. Results of PBT and vPvB assessment

No data available.

Not a PBT or vPvB substance or mixture.

 

12.6. Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation potential, endocrine disruption, global warming potential) are expected from this component.

 

SECTION 13: Disposal considerations

13.1. Waste treatment methods

 

Residual waste

 

 

Contaminated packaging

 

 

EU waste code

 

Disposal methods/information

Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).

Empty containers should be taken to an approved waste handling site for recycling or disposal. Since emptied containers may retain product residue, follow label warnings even after container is emptied.

The Waste code should be assigned in discussion between the user, the producer and the waste disposal company.

Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose of contents/container in accordance with local/regional/national/international regulations.

 

SECTION 14: Transport information

ADR

Not regulated as dangerous goods.

RID

Not regulated as dangerous goods.

ADN

Not regulated as dangerous goods.

IATA

Not regulated as dangerous goods.

IMDG

Not regulated as dangerous goods.

 

14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

Not applicable.

 

SECTION 15: Regulatory information

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture EU regulations

Regulation (EC) 005/2009 on substances that deplete the ozone layer, Annex I and II, as amended

Not listed.

Regulation (EC) No 850/2004 On persistent organic pollutants, Annex I as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 1 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 2 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 3 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex V as amended

Not listed.

Regulation (EC) No 166/2006 Annex II Pollutant Release and Transfer Registry, as amended

Not listed.

Regulation (EC) 907/2006, REACH Article 59(10) Candidate List as currently published by ECHA

Not listed.

Authorisations

Regulation (EC) 907/2006, REACH Annex XIV Substances subject to authorization, as amended

Not listed.

Restrictions on use

Regulation (EC) No1907/2006, REACH Annex XVII Substances subject to restriction on marketing and use as amended

Not listed.

Directive 2004/37/EC: on the protection of workers from the risks related to exposure to carcinogens and mutagens at work, as amended

Not listed.

Directive 92/85/EEC: on the safety and health of pregnant workers and workers who have recently given birth or are breastfeeding, as amended

Not listed.

Other EU regulations

Directive 2012/18/EU on major accident hazards involving dangerous substances

Not listed.

 

Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

Not listed.

Directive 94/33/EC on the protection of young people at work

Not listed.

 

Other regulations

 

 

 

 

National regulations

15.2. Chemical safety assessment

The product is classified and labelled in accordance with Regulation (EC) 1272/2008 (CLP Regulation) as amended and respective national laws implementing EC directives. This Safety Data Sheet complies with the requirements of Regulation (EC) 907/2006.

In the European Union this product is regulated under the In Vitro Diagnostic Medical Devices Directive (98/79/EC).

Follow national regulation for work with chemical agents. No Chemical Safety Assessment has been carried out.

 

SECTION 16: Other information

List of abbreviations

 

 

 

References

Information on evaluation method leading to the classification of mixture

Full text of any H-statements not written out in full under Sections 2 to 15

 

 

Training information Disclaimer

DNEL: Derived No-Effect Level.

PNEC: Predicted No-Effect Concentration.

IARC Monographs. Overall Evaluation of Carcinogenicity

The classification for health and environmental hazards is derived by a combination of calculation methods and test data, if available.

 

 

 

H315 Causes skin irritation.

H319 Causes serious eye irritation. H335 May cause respiratory irritation.

Follow training instructions when handling this material.

The information above is provided in good faith. It is believed to be accurate and represents the best information currently available to us. HOWEVER, WE MAKE NO WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER TYPE, EXPRESSED OR IMPLIED, WITH RESPECT TO PRODUCTS DESCRIBED OR DATA OR INFORMATION PROVIDED, AND WE ASSUME NO LIABILITY RESULTING FROM THE USE OF

SUCH PRODUCTS, DATA OR INFORMATION. Users should make their own investigations to determine the suitability of the information for their particular purposes, and the user assumes all risk arising from their use of the material. The user is required to comply with all laws and regulations relating to the purchase, use, storage and disposal of the material, and must be familiar with and follow generally accepted safe handling procedures. In no event shall BioMedica Diagnostics be liable for any claims, losses, or damages of any individual or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if BioMedica Diagnostics has been advised of the possibility of such damages.

 

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

bmgrp2022年价格表

     我们的使命是为临床前和临床应用开发和制造高质量的免疫分析。成立于1988年,在免疫分析的发展方面有30多年的经验。2018年奥地利BioMedica Diagnostics Inc 试剂盒。bmgrp是我们经销的品牌之一。

https://www.bmgrp.com/,  Biomedica Medizinprodukte GmbH.

更多报价欢迎下载附件。

货号 品名 规格 价格 品牌 货期 报价来源
BI-20022* MDA-oxLDL ELISA 12x8tests 7480 bmgrp 4 上海金畔
BI-20032 oLAB ELISA 12x8tests 8580 bmgrp 4 上海金畔
BI-20082H Big Endothelin ELISA 12x8tests 8360 bmgrp 4 上海金畔
BI-20403 OPG ELISA 12x8tests 8030 bmgrp 4 上海金畔
BI-20405 Semaphorin 4D ELISA 12x8tests 10010 bmgrp 4 上海金畔
BI-20409 total Neuropilin-1 ELISA 12x8tests 8800 bmgrp 4 上海金畔

biomedicadiagnostics2024年价格表

biomedicadiagnostics2024年价格表

BioMedica是一家加拿大公司,也是斯科舍投资公司家族的成员。

BioMedica灵活且适应性强,在研发,合作研究,产品开发和制造方面拥有专业知识。

BioMedica Diagnostics创建于1999年,是一家专注于为人类和动物健康领域提供定制的加拿大公司。目标是向世界新兴经济体提供产品。

biomedicadiagnostics专长为小型诊所和医院提供心血管诊断,biomedicadiagnostics在全球、人类和动物健康领域提供定制、经济实惠的诊断解决方案。我们努力降低成本,降低和减轻所有利益相关者的风险,开发研究、教育和体外诊断所需的工具。

我们在研发、合作研究、产品开发和制造以及试点批次开发和扩大方面拥有丰富的专业知识,具有敏捷性和适应性。

特别告知:为保证产品质量与良好性能,所以在购买相应产品的同时我司会收取一定量的运输费用!!!本次报价有效时间为2024年1月1日—2024年12月31日。

货号 品名 规格 价格 品牌 货期 价格来源
155 Streptokinase, 10 MIU EA 23002.4 biomedicadiagnostics 4-6周 上海金畔
222 SPECTROZYME® FXa, 5 μmole vial EA 837 biomedicadiagnostics 4-6周 上海金畔
222B SPECTROZYME® FXa, 0.5 gram vial EA 44242 biomedicadiagnostics 4-6周 上海金畔
222F SPECTROFLUOR™ FXa, fluorogenic substrate for FXa, 10 μmole EA 3338.2 biomedicadiagnostics 4-6周 上海金畔
222L SPECTROZYME® FXa, 50 μmole vial EA 5198.2 biomedicadiagnostics 4-6周 上海金畔
237 Thrombomodulin, rabbit lung, 30 x 1 mL EA 5929.8 biomedicadiagnostics 4-6周 上海金畔
238B SPECTROZYME® TH, 0.5 gram vial EA 43804 biomedicadiagnostics 4-6周 上海金畔
238 SPECTROZYME® TH, 5 μmole vial EA 817.6 biomedicadiagnostics 4-6周 上海金畔
238L SPECTROZYME® TH, 50 μmole vial EA 5256.6 biomedicadiagnostics 4-6周 上海金畔
245 Protac®, direct protein C activator, 3 units EA 2355.8 biomedicadiagnostics 4-6周 上海金畔


关键词:biomedicadiagnostics、心血管诊断、血栓形成、止血、抗凝

Biomedica代理


Biomedica代理

简要描述:Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
上海金畔生物科技有限公司Biomedica专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
上海金畔生物科技有限公司Biomedica专业代理,具体产品信息欢迎电询:

BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断和价廉物美的医疗诊断解决方案。BioMedica提供完整的配套便携式仪器、诊断化学药品、实验室器具和配件,便于使用。产品包括血液化学试剂套件、尿液分析测试条、HIV测试和监控设备。BioMedica的产品是QuikCoag化学试剂系列, 用于诊断心脏病等疾病。公司创始人兼*执行长Abdullah Kirumira博士经常因向资源有限的国家提供医药的独*献而受到表彰。 zui近获得世界经济论坛颁发的2009年新兴经济体价廉物美医疗诊断技术开创奖。
http://www.biomedica.co.at/

 

上海金畔生物科技有限公司

BioMedica Diagnostics Inc.代理


BioMedica Diagnostics Inc.代理

简要描述:BioMedica Diagnostics Inc.代理,BioMedica Diagnostics Inc. 上海代理, BioMedica Diagnostics Inc. 代理, , BioMedica Diagnostics Inc. 代理
上海金畔生物科技有限公司 BioMedica Diagnostics Inc. 专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

世界*实验材料供应商 BioMedica Diagnostics Inc.正式上海金畔为其中国代理, BioMedica Diagnostics Inc.在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔一直秉承为中国科研客户带来的产品,的服务, BioMedica Diagnostics Inc.就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 BioMedica Diagnostics Inc.中国代理, BioMedica Diagnostics Inc.上海代理, BioMedica Diagnostics Inc.北京代理,BioMedica Diagnostics Inc.广东代理, BioMedica Diagnostics Inc.江苏代理BioMedica Diagnostics Inc. 湖北代理,BioMedica Diagnostics Inc.天津,BioMedica Diagnostics Inc.黑龙江代理,BioMedica Diagnostics Inc.内蒙古代理,BioMedica Diagnostics Inc.吉林代理,BioMedica Diagnostics Inc.福建代理, BioMedica Diagnostics Inc.江苏代理, BioMedica Diagnostics Inc.浙江代理, BioMedica Diagnostics Inc.四川代理,

BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断

http://www.biomedicadiagnostics.com/

BioMedica is a Canadian Medical Devices Company ready to be your partner in human and animal hemostasis and thrombosis.

Based in Windsor, Nova Scotia, Canada, with manufacturing and warehousing facilities, research laboratories, as well as sales, marketing and administrative offices.  BioMedica markets and distributes products worldwide – North America, Europe, Latin America, Asia, Middle East and Africa.

 

上海金畔生物科技有限公司

Biomedica


Biomedica代理

简要描述:Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断和价廉物美的医疗诊断解决方

详细介绍

产品咨询

Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
上海金畔生物科技有限公司Biomedica专业代理,具体产品信息欢迎电询:021-50837765

BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断和价廉物美的医疗诊断解决方案。BioMedica提供完整的配套便携式仪器、诊断化学药品、实验室器具和配件,便于使用。产品包括血液化学试剂套件、尿液分析测试条、HIV测试和监控设备。BioMedica的产品是QuikCoag化学试剂系列, 用于诊断心脏病等疾病。公司创始人兼*执行长Abdullah Kirumira博士经常因向资源有限的国家提供医药的独*献而受到表彰。 zui近获得世界经济论坛颁发的2009年新兴经济体价廉物美医疗诊断技术开创奖。
http://www.biomedica.co.at/

 

上海金畔生物科技有限公司
实验试剂一站式采购服务商
1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。
2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。
3:提供加急服务,货品一般1-2周到货。
4:富有竞争力的价格优势,绝大部分价格有优势。
5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。
6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。
7:我们还是invitrogen,qiagen,abcam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。